// App-Quantinova.ai

321 2016 ATVB : Prasugrel, a Platelet P2y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hind Limb Ischaemia

Researchers

Presenter

  • Atsuyuki Tomizawa

Principal Investigators

  • Makoto Mizuno

  • Joseph A. Jakubowski

  • Atsuhiro Sugidachi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Daiichi Sankyo Compa

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Peripheral artery disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved